본문 바로가기
KERD
논문KCI 등재

Lactoferrin Induces Tolerogenic Bone Marrow-Derived Dendritic Cells

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that initiate both T-cell responses and tolerance. Tolerogenic DCs (tDCs) are regulatory DCs that suppress immune responses through the induction of T-cell anergy and Tregs. Because lactoferrin (LF) was demonstrated to induce functional Tregs and has a protective effect against inflammatory bowel disease, we explored the tolerogenic effects of LF on mouse bone marrow-derived DCs (BMDCs). The expression of CD80/86 and MHC class II was diminished in LF-treated BMDCs (LF-BMDCs). LF facilitated BMDCs to suppress proliferation and elevate Foxp3+ induced Treg (iTreg) differentiation in ovalbumin-specific CD4+ T-cell culture. Foxp3 expression was further increased by blockade of the B7 molecule using CTLA4-Ig but was diminished by additional CD28 stimulation using anti-CD28 Ab. On the other hand, the levels of arginase-1 and indoleamine 2,3-dioxygenase-1 (known as key T-cell suppressive molecules) were increased in LF-BMDCs. Consistently, the suppressive activity of LF-BMDCs was partially restored by inhibitors of these molecules. Collectively, these results suggest that LF effectively causes DCs to be tolerogenic by both the suppression of T-cell proliferation and enhancement of iTreg differentiation. This tolerogenic effect of LF is due to the reduction of costimulatory molecules and enhancement of suppressive molecules.

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that initiate both T-cell responses and tolerance. Tolerogenic DCs (tDCs) are regulatory DCs that suppress immune responses through the induction of T-cell anergy and Tregs. Because lactoferrin (LF) was demonstrated to induce functional Tregs and has a protective effect against inflammatory bowel disease, we explored the tolerogenic effects of LF on mouse bone marrow-derived DCs (BMDCs). The expression of CD80/86 and MHC class II was diminished in LF-treated BMDCs (LF-BMDCs). LF facilitated BMDCs to suppress proliferation and elevate Foxp3+ induced Treg (iTreg) differentiation in ovalbumin-specific CD4+ T-cell culture. Foxp3 expression was further increased by blockade of the B7 molecule using CTLA4-Ig but was diminished by additional CD28 stimulation using anti-CD28 Ab. On the other hand, the levels of arginase-1 and indoleamine 2,3-dioxygenase-1 (known as key T-cell suppressive molecules) were increased in LF-BMDCs. Consistently, the suppressive activity of LF-BMDCs was partially restored by inhibitors of these molecules. Collectively, these results suggest that LF effectively causes DCs to be tolerogenic by both the suppression of T-cell proliferation and enhancement of iTreg differentiation. This tolerogenic effect of LF is due to the reduction of costimulatory molecules and enhancement of suppressive molecules.

참고문헌 (38)

  1. Banchereau J, "Dendritic cells and the control of immunity", Nature, 392, pp.245~252 (1998)
  2. Morelli AE, "Dendritic cells : regulators of alloimmunity and opportunities for tolerance induction", Immunol Rev, 196, pp.125~146 (2003)
  3. Hubo M, "Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells", Front Immunol, 4, pp.82~ (2013)
  4. Svajger U, "Tolerogenic dendritic cells : molecular and cellular mechanisms in transplantation", J Leukoc Biol, 95, pp.53~69 (2014)
  5. Turnquist HR, "Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance", J Immunol, 178, pp.7018~7031 (2007)
  6. Munder M, "Th1", Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells, 1999, pp.163, 3771~3777
  7. Hwu P, "Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation", J Immunol, 164, pp.3596~3599 (2000)
  8. Rodriguez PC, "L-arginine availability regulates T-lymphocyte cell-cycle progression", Blood, 109, pp.1568~1573 (2007)
  9. Munn DH, "Potential regulatory function of human dendritic cells expressing indoleamine 2, 3-dioxygenase", Science, 297, pp.1867~1870 (2002)
  10. Mizumoto N, "CD39 is the dominant Langerhans cell-associated ecto-NTPDase : modulatory roles in inflammation and immune responsiveness", Nat Med, 8, pp.358~365 (2002)
  11. Unger WW, "Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone : differential role for PD-L1", Eur J Immunol, 39, pp.3147~3159 (2009)
  12. Legrand D, "Lactoferrin : a modulator of immune and inflammatory responses", Cell Mol Life Sci, 62, pp.2549~2559 (2005)
  13. Moreno-Expósito L, "Multifunctional capacity and therapeutic potential of lactoferrin", Life Sci, 195, pp.61~64 (2018)
  14. Håversen L, "Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB", Cell Immunol, 220, pp.83~95 (2002)
  15. Togawa J, "Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance", J Gastroenterol Hepatol, 17, pp.1291~1298 (2002)
  16. Zimecki M, "Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats", J Neuroimmunol, 182, pp.160~166 (2007)
  17. Yin H, "Lactoferrin protects against concanavalin A-induced liver injury in mice", Liver Int, 30, pp.623~632 (2010)
  18. Kim PH, "Mechanism underlying the induction of Foxp3+ regulatory T cells by lactoferrin", J Immunol, 200, pp.47~ (2018)
  19. Bhatt S, "All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function", J Immunol, 192, pp.5098~5108 (2014)
  20. Turner MS, "Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion", J Immunol, 183, pp.4895~4903 (2009)
  21. Semple K, "Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling", Blood, 117, pp.3096~3103 (2011)
  22. Xia CQ, "Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity", Scand J Immunol, 62, pp.45~54 (2005)
  23. Kim N, "Minocycline promotes the generation of dendritic cells with regulatory properties", Oncotarget, 7, pp.52818~52831 (2016)
  24. Lee JH, "Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone", Sci Rep, 7, pp.15087~ (2017)
  25. Parry RV, "CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes", J Immunol, 171, pp.166~174 (2003)
  26. Kim JM, "The role of the transcription factor Foxp3 in the development of regulatory T cells", Immunol Rev, 212, pp.86~98 (2006)
  27. Chang J, "Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation", Eur J Immunol, 43, pp.967~978 (2013)
  28. Chung DJ, "Indoleamine 2, 3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells", Blood, 114, pp.555~563 (2009)
  29. Creery WD, "Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype", Eur J Immunol, 26, pp.1273~1277 (1996)
  30. Elass-Rochard E, "Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein", Infect Immun, 66, pp.486~491 (1998)
  31. Tze LE, "CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation", J Exp Med, 208, pp.149~165 (2011)
  32. Davidson LA, "Persistence of human milk proteins in the breast-fed infant", Acta Paediatr Scand, 76, pp.733~740 (1987)
  33. Kim PH, "Transforming growth factor beta 1 increases IgA isotype switching at the clonal level", J Immunol, 145, pp.3773~3778 (1990)
  34. Jang YS, "Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling", Mucosal Immunol, 8, pp.906~917 (2015)
  35. Cong Y, "A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota", Proc Natl Acad Sci U S A, 106, pp.19256~19261 (2009)
  36. Tsuji M, "Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches", Science, 323, pp.1488~1492 (2009)
  37. Masson PL, "Lactoferrin, an iron-binding protein in neutrophilic leukocytes", J Exp Med, 130, pp.643~658 (1969)
  38. phenotype and drives resolution of inflammation in distinct murine models of inflammatory bowel disease, "J Crohns Colitis", 2017, 1101~1112

관련 논문AI추천

이 간행물의 다른 논문 (7건)